Metraipolis › archive › dc_53d68ec40de9

A randomized controlled phase Ia clinical trial to evaluate the safety, tolerability and pharmacokinetic characteristics of tofacitinib tartrate cream… — Europe PMC PMID:42181873

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42181873
DOI
10.3389/fphar.2026.1821901
License (as archived)
solo-consultazione
Archived
2026-11-02T14:14:49.454Z
SHA-256 of the archived text
14195eb9e13d50e1c208857bdb7c98fc93bf1738ac4938cf211fb1b2ba12d321
Stable URL of this page
https://metraipolis.com/documento/dc_53d68ec40de9

How to cite

A randomized controlled phase Ia clinical trial to evaluate the safety, tolerability and pharmacokinetic characteristics of tofacitinib tartrate cream… — Europe PMC PMID:42181873 — Europe PMC (en), https://europepmc.org/article/MED/42181873 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_53d68ec40de9 (Metraipolis archive dc_53d68ec40de9, sha256 14195eb9e13d50e1c208857bdb7c98fc93bf1738ac4938cf211fb1b2ba12d321)
BibTeX
@misc{dc53d68ec40de9,
  title = {A randomized controlled phase Ia clinical trial to evaluate the safety, tolerability and pharmacokinetic characteristics of tofacitinib tartrate cream… — Europe PMC PMID:42181873},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42181873},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_53d68ec40de9; sha256 14195eb9e13d50e1c208857bdb7c98fc93bf1738ac4938cf211fb1b2ba12d321},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42181873. Agents can read the archived copy with the MCP tool read_document.